CSBR vs IONS · P/E 16, rev $56.9M vs rev $226.6M
Champions Oncology Inc (CSBR) versus Ionis Pharmaceuticals Inc (IONS) — a side-by-side from cached financials, not a winner call.
Champions Oncology Inc (CSBR) is a biotechnology company listed on US.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
Latest reported CSBR revenue for 2025-04-30 was $56.9M. Net income was $4.7M. CSBR currently screens at market cap $99.8M and trailing P/E 16.0.
Latest reported IONS revenue for 2024-12-31 was $226.6M. Net income was -$104.3M. Revenue was down 30.2% from 2023-12-31 to 2024-12-31. IONS currently screens at market cap $12.28B.
CSBR currently screens at market cap $99.8M and trailing P/E 16.0. IONS currently screens at market cap $12.28B.
Not investment advice. Open the CSBR and IONS stock pages for the full models.
Not investment advice.